4.6 Review

Integrated Care in Parkinson's Disease: A Systematic Review andMeta-Analysis

Journal

MOVEMENT DISORDERS
Volume 35, Issue 9, Pages 1509-1531

Publisher

WILEY
DOI: 10.1002/mds.28097

Keywords

integrated care; meta-analysis; multidisciplinary team; Parkinson's disease

Funding

  1. DST-SERB
  2. Michael J. Fox Foundation
  3. All India Institute of Medical Sciences, New Delhi
  4. Netherlands Organization for Scientific Research
  5. UCB
  6. AbbVie
  7. Stichting Parkinson Fonds
  8. Hersenstichting Nederland
  9. Parkinson's Foundation
  10. Verily Life Sciences
  11. Horizon 2020
  12. Topsector Life Sciences and Health
  13. Gatsby Foundation
  14. Parkinson Vereniging
  15. Civitas Therapeutics
  16. Parkinson Canada
  17. Ontario Brain Institute
  18. PSI Foundation
  19. Parkinson Research Consortium
  20. uOBMRI
  21. CIHR
  22. Hungarian Brain Research Program [2017-1.2.1-NKP-2017-00002]
  23. NKFIH [EFOP3.6.2-16-2017-00008, SNN125143]
  24. Higher Education Institutional Excellence Programme of the Ministry for Innovation and Technology in Hungary, within University of Pecs
  25. AbbVie Pharmaceuticals
  26. DongA
  27. Pharma2B
  28. Impax
  29. Theravance
  30. Park Nicolet Foundation
  31. Biotie Therapies
  32. DBT

Ask authors/readers for more resources

Background Quality of life in Parkinson's disease (PD) is affected by motor and nonmotor symptoms, necessitating an integrated care approach. Existing care models vary considerably in numerous domains. The objectives of this study were to perform a systematic review and meta-analysis of PD integrated care models and develop recommendations for a representative model. Methods We conducted a systematic review of published integrated care models and a meta-analysis of randomized, controlled trials examining integrated care versus standard care. The primary outcome was health-related quality of life using a validated PD scale. We evaluated levels of care integration using the Rainbow Model of Integrated Care. Results Forty-eight publications were identified, including 8 randomized, controlled trials with health-related quality of life data (n = 1,149 total PD patients). Qualitative evaluation of individual care model integration guided by the Rainbow Model of Integrated Care revealed frequent clinical and professional integration, but infrequent organizational and population-based integration elements. Meta-analysis of randomized, controlled trials revealed significant heterogeneity (I-2 = 90%,P< 0.0001). Subgroup analysis including only outpatient care models (n = 5) indicated homogeneity of effects (I-2 = 0%,P= 0.52) and improved health-related quality of life favoring integrated care, with a small effect size (standardized mean difference [SMD], -0.17; 95% CI, -0.31 to -0.03;P= 0.02). Conclusions Outpatient integrated PD care models may improve patient-reported health-related quality of life compared with standard care; however, because of variable methodological approaches and a high risk of bias related to inherent difficulties in study design (eg, blinding of participants and interventionists), generalizability of these results are difficult to establish. The Rainbow Model of Integrated Care is a promising method of evaluating elements and levels of integration from individual patient care to population health in a PD context. (c) 2020 The Authors.Movement Disorderspublished by Wiley Periodicals, LLC. on behalf of International Parkinson and Movement Disorder Society.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available